BSEM — Biostem Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $165.72m
- $171.63m
- $4.34m
- 11
- 22
- 89
- 35
Annual cashflow statement for Biostem Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | R2016 December 31st | 2017 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | ARS | ARS | ARS | ARS |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.38 | -3.2 | -4.84 | -2.37 | -1.41 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.6 | 1.65 | 2.33 | 0.628 | -0.142 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.378 | -0.315 | 0.421 | 0.916 | 0.642 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.354 | -1.7 | -1.89 | -0.582 | -0.625 |
| Capital Expenditures | -1.8 | -0.623 | -0.156 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.061 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.8 | -0.623 | -0.156 | — | 0.061 |
| Financing Cash Flow Items | — | 0.033 | 0.068 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.51 | 2.05 | 1.92 | 0.542 | 0.804 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.361 | -0.285 | -0.128 | -0.04 | 0.24 |